##common.pageHeaderLogo.altText##
DOI:
https://doi.org/10.4414/smw.2014.13949

Technical comment

Vol. 144 No. 1516 (2014)

Early detection of urinary NGAL and plasma CysC may prevent progression to overt acute renal failure

  • Hakan Sarlak
  • Mustafa Dinc
  • Sevket Balta
  • Mustafa Cakar
  • Erol Arslan
  • Seref Demirbas
Cite this as:
Swiss Med Wkly. 2014;144:w13949
Published
06.04.2014

References

  1. Seitz S, Rauh M, Gloeckler M, et al. Cystatin C and neutrophil gelatinase-associated lipocalin: biomarkers for acute kidney injury after congenital heart surgery. Swiss Med Wkly. 2013;143: w13744 http://www.smw.ch/content/smw-2013-13744/.
  2. Perrin T, Descombes E, Cook S. Contrast-induced nephropathy in invasive cardiology. Swiss Med Wkly. 2012;142:w13608 http://www.smw.ch/content/smw-2012-13608/.
  3. Riccia Z, Roncob C. New insights in acute kidney failure in the critically ill. Swiss Med Wkly. 2012;142:w13662 http://www.smw.ch/content/smw-2012-13662/.
  4. Kocha AM, Dittricha S, Cesnjevarb R, et al. Plasma neutrophil gelatinase-associated lipocalin measured in consecutive patients after congenital heart surgery using point-of-care technology. Interact Cardiovasc Thorac Surg. 2011;13:133–6.
  5. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Progression of Chronic Kidney Disease. Clin J Am Soc Nephrol. 2009;4:337–44.

Most read articles by the same author(s)